Skip to content

Itraconazole (200 mg)

DRUG10 trials

Sponsors

H. Lundbeck A/S, Lomond Therapeutics Holdings, Inc., Immunome, Inc., Urooj Fatima, Pak Emirates Military Hospital

Conditions

AMLCytochrome P450 InteractionDermatophytosisDrug InteractionsHealthyHealthy Adult ParticipantsHealthy VolunteerSeborrheic Dermatitis

Early Phase 1

Phase 1

Study Evaluating the Effect of Multiple Doses of Itraconazole on the Drug Lu AF35700 in Healthy Young Men and Women
CompletedNCT03103646
H. Lundbeck A/SCytochrome P450 Interaction
Start: 2017-03-28End: 2019-07-19Updated: 2019-10-02
Study of Single and Multiple Ascending Doses of ZE46-0134 in Healthy Volunteers
CompletedNCT06399315
Lomond Therapeutics Holdings, Inc.AML
Start: 2023-07-28End: 2025-08-26Updated: 2025-12-09
A Phase 1 Study to Examine the Effects of Itraconazole After Single Dose Administration of Varegacestat (AL102) to Healthy Participants
CompletedNCT06677996
Immunome, Inc.Healthy Volunteer
Start: 2024-11-11End: 2025-05-07Updated: 2025-05-11
Clinical Study Aiming to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of a Single Administration of ZE50-0134 at 5 Dose Levels in Healthy Volunteers
CompletedNCT06787131
Lomond Therapeutics Holdings, Inc.Healthy
Start: 2024-05-21End: 2025-07-04Updated: 2025-12-05
A Phase 1 Multiple Dose Trial in Healthy Adult Participants to Evaluate the Safety, Tolerability, Drug-Drug Interactions, and Pharmacokinetics of TBD11
RecruitingNCT07883226
Gates Medical Research InstituteHealthy Adult Participants
Start: 2026-10-21End: 2027-05-30Target: 66Updated: 2026-10-22
A Study to Evaluate the Effect of Carbamazepine or Itraconazole on Radiprodil in Healthy Adult Participants
Active, not recruitingNCT07884734
GRIN Therapeutics, Inc.Healthy Adult Participants
Start: 2026-06-08End: 2026-10-31Target: 36Updated: 2026-10-21
Effect of Itraconazole on the Pharmacokinetics of Intravenous HRS-4642 in Healthy Participants
Not yet recruitingNCT07894679
The Third Xiangya Hospital of Central South UniversityDrug Interactions
Start: 2026-10-01End: 2026-11-01Target: 18Updated: 2026-10-26

Phase 4

Related Papers